Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Željko Metelko is active.

Publication


Featured researches published by Željko Metelko.


PharmacoEconomics | 1998

Quality of life following a change in therapy for diabetes mellitus.

Mirjana Pibernik-Okanović; Silvija Szabo; Željko Metelko

Objective:The study objective was to evaluate and compare quality-of-life (QOL) parameters between patients with type 2 (non-insulin-dependent) diabetes mellitus who changed therapy from an oral hypoglycaemic agent (OHA) to insulin and those who remained on an OHA.Design:The World Health Organization Quality of Life Questionnaire (WHOQOL) was used to assess quality of life among 2 groups of patients with type 2 diabetes mellitus at baseline and after a 2-month follow-up period.Setting:The study was conducted in the outpatient department of the Vuk Vrhovac Clinic, a referral centre for registration, treatment and follow-up of patients with diabetes mellitus in Zagreb, Croatia.Participants and Interventions:32 consecutively recruited patients with type 2 diabetes mellitus who were switched from an OHA to insulin therapy (group 1) were compared with 28 patients who remained on OHA (group 2) with respect to QOL issues. The patient groups were comparable in terms of gender, age, duration of disease, education and family status. However, patients in group 1 had glycosylated haemoglobin (HbA1c) values greater than 9.5% on average during a period of approximately 6 months, which was the criterion used for switching to insulin therapy.Main Outcome Measures and Results:At baseline, various QOL ratings were higher among patients in group 2 than group 1, indicating better quality of life with respect to overall quality of life (t = −2.31, p = 0.03), physical health (t = −2.36, p = 0.02), psychological state (t = −2.01, p = 0.05) and level of independence (t = −2.75, p = 0.001), while no differences were found between groups with respect to the social domain, personal beliefs and environmental QOL aspects. After the follow-up period, the groups were comparable in all QOL aspects other than overall quality of life (t = −2.18, p = 0.03) and level of independence (t = −3.49, p = 0.001), both of which remained higher for patients in group 2. No changes in QOL parameters were detected within group 2 from baseline to the end of the 2-month follow-up period, whereas patients in group 1 showed significant improvement in psychological QOL determinants (t = −2.14, p = 0.04).Conclusion:Results of the study indicate that introducing insulin therapy in patients with type 2 diabetes mellitus and sustained elevated HbA1c levels might positively affect their quality of life.


Diabetes Research and Clinical Practice | 2008

Prevalence of diabetes mellitus in Croatia

Željko Metelko; Ivana Pavlić-Renar; Tamara Poljičanin; Lajos Szirovitza; Stjepan Turek

The aim of this study was to obtain an accurate estimate of diabetes prevalence in Croatia and additional estimates of impaired fasting glucose (IFG), undiagnosed diabetes, and insulin resistance. The study was part of the First Croatian Health Project. Field work included a questionnaire, anthropological measurements, and blood sampling. A nationally representative sample of 1653 subjects aged 18-65 years was analyzed. A total of 100 participants with diabetes were detected, among them 42 with previously unknown diabetes. The prevalence was 6.1% (95% CI: 4.59-7.64), with a significant difference by age. IFG prevalence (WHO-criteria) was 11.3%. The ratio of undiagnosed/diagnosed diabetes was 72/100, unevenly distributed by the regions. HOMA-IR was >1 in 40.4% of the subjects. This survey revealed a higher prevalence of diabetes than previously estimated, whereas that of IFG was as expected. A significant difference in the proportion of undiagnosed diabetes among the regions warrants attention.


Journal of Diabetes and Its Complications | 2001

Relationship between autonomic function, 24-h blood pressure, and albuminuria in normotensive, normoalbuminuric patients with Type 1 diabetes

Lea Duvnjak; Sandra Vučković; Nikica Car; Željko Metelko

We performed a battery of cardiovascular reflex tests, 24-h ambulatory blood pressure (AMBP) and 24-h urinary albumin excretion (UAE) in 116 normoalbuminuric and normotensive patients with Type 1 diabetes. Tests of heart rate variation (HRV) included the coefficient of variation (CV) and the low-frequency (LF), mid-frequency (MF), and high-frequency (HF) bands of spectral analysis at rest, HRV during deep breathing (CV, mean circular resultant--MCR), Valsalva ratio, and maximum/minimum 30:15 ratio. Autonomic neuropathy, characterized as an abnormality of more than two tests, was found in 33 patients. Patients with neuropathy compared to those without neuropathy showed significantly higher mean day and night diastolic blood pressure (dBP), mean systolic night blood pressure (sBP), and mean day and night heart rate (HR). Mean night dBP was inversely related to MF, HF, and HRV during deep breathing; mean day dBP and mean night sBP to HF; mean night HR to CV at rest, MF, HF, HRV during deep breathing, 30:15 ratio; mean day HR to HF, HRV during deep breathing, Valsalva, and 30:15 ratio. Mean 24-h UAE was not significantly different in neuropathic than in nonneuropathic patients. UAE was inversely related to CV at rest and HF. In the stepwise multiple regression analysis, reduced MF, HF, HRV during deep breathing, and high levels of UAE and HbA1c were associated with high night dBP. Autonomic neuropathy is already present in normotensive Type 1 diabetic patients at the normoalbuminuric stage and related to BP and albuminuria.


Diabetologia | 1995

Incidence of IDDM during 1988–1992 in Zagreb, Croatia

Gojka Roglić; Ivana Pavlić-Renar; S. Šestan-Crnek; Manja Prašek; Magda Kadrnka-Lovrenčić; Ana Radica; Željko Metelko

SummaryThe objective of this study was to determine the incidence of insulin-dependent diabetes mellitus (IDDM) in the population of Zagreb, Croatia, during 1988–1992. A centralized diabetes registry was the primary source of data, while secondary sources were used to assess ascertainment. A total of 282 new cases of IDDM were diagnosed in the study period, the primary and secondary sources identifying annually 93–100% of the cases. The annual incidence rate ranged from 5.6 per 100,000 to 6.6 per 100,000. Early fatality in persons older than 50 years was the major cause of underascertainment. The incidence peaked in the 10–14 years age group (12.4 per 100,000), and remained stable after age 24 years. Males had a significantly higher incidence in the 5–9 and 24–44 years age groups. In the 45–54 years age group, females had a significantly higher incidence. No seasonality was observed. Despite the war conditions in Croatia, the low overall IDDM incidence rates did not change significantly during the study period.


Diabetes Research and Clinical Practice | 1996

Emotional adjustment and metabolic control in newly diagnosed diabetic persons

Mirjana Pibernik-Okanović; Gojka Roglic; Manja Prašek; Željko Metelko

Emotional reactions to diagnosis were examined in a random sample of newly detected diabetic patients (n = 71) and compared with the indicators of glycemic control in a one-year-follow-up period. The social and emotional factors subscale of the diabetes care profile was used to determine the subjectively experienced burden, negative feelings and positive coping abilities. The initial struggle against the disease indicated three characteristic emotional patterns. Feelings of being able to cope with the disease predominated in group 1 (n = 36), negative emotional reactions, but with the ability to cope were observed in group 2 (n = 17) and negative feelings combined with weak coping abilities in group 3 (n = 18). The long-term indicators of glycemic control were shown to be worst in group 3 and best in group 1. Subjective perception of the disease was not associated with sociodemographic variables, with the exception of perceived coping abilities which were better in more educated persons and those with more familial support.


Acta Diabetologica | 2004

A pilot study of mitochondrial DNA point mutation A3243G in a sample of Croatian patients having type 2 diabetes mellitus associated with maternal inheritance

Irena Martin-Kleiner; Edita Pape-Medvidović; Ivana Pavlić-Renar; Željko Metelko; Rajko Kusec; Jelka Gabrilovac; Milivoj Boranić

In this work, patients having type 2 diabetes mellitus and diabetic mothers were tested for the presence of mitochondrial DNA point mutation A3243G. This mutation is associated with the MELAS syndrome (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), diabetes and deafness. Twenty-two diabetic persons were screened. DNA was isolated from peripheral blood lymphocytes and from swabs of oral mucosa. The mitochondrial DNA point mutation A3243G was detected using PCR-RFLP test. The mutation was detected in oral mucosal DNA of two patients (but not from lymphocyte DNA). One patient was a man with hearing and visual impairments and proteinuria; the other was a woman having proteinuria but no hearing impairment. The mutation was not detectable in oral mucosal DNA from the control persons: 20 diabetic patients having diabetic fathers and 22 healthy, nondiabetic volunteers. The incidence of mitochondrial DNA point mutation A3243G in this study of Croatian diabetic patients is in line with data in the literature.


Diabetes Research and Clinical Practice | 2000

Quality of life in diabetic, otherwise III and healthy persons

Mirjana Pibernik-Okanović; Silvija Szabo; Željko Metelko

Sixty-five diabetic persons were compared with 185 otherwise ill and 50 healthy persons in order to highlight quality of life issuess. The samples were balanced with respect to gender, education and family status, while age was lower in the healthy persons group (diabetic: 46.6 yrs +/-15.6 ; otherwise ill: 45.4 years +/-15.5 ; healthy persons 38.8 yrs +/-14.6 p=0.014). The World Health Quality of Life questionnaire (WHOQOL-100) was applied to assess the individual quality of life. The WHOQOL inquires into the respondents perception and subjective evaluation of overall quality of life and general health, as well as 6 quality of life domains: physical, psychological, level of independence, social relationships, environment and spirituality/religion/personal beliefs domain. Analysis of variance was used to compare diabetic versus otherwise ill and healthy subjects. The group variability was statistically significant with regard to physical domain (F=18.98 p=0.0001), and level of independence (F=26.83 p=0.0001). The Scheffe test revealed that healthy persons gave significantly higher ratings, indicating better quality of life, than both unwell groups. Diabetic persons gave higher ratings for the physical domain than other unwell persons. F ratio significance remained unchanged with age as covariate. The results in particular facets indicate that diabetic persons are mostly disturbed with regard to their energy level, mobility, activities of daily living and working capacity, but do not differ from the healthy persons in positive feelings, negative feelings, self-esteem, body image, cognitive abilities and social relationships.


Chest | 1998

Reduction of Diffusion Capacity for Carbon Monoxide in Diabetic Patients

Spomenka Ljubić; Željko Metelko; Nikica Car; Gojka Roglic; Zrinka Dražić


BMC Public Health | 2010

Diabetes mellitus and hypertension have comparable adverse effects on health-related quality of life

Tamara Poljičanin; Dea Ajduković; Mario Šekerija; Mirjana Pibernik-Okanović; Željko Metelko; Gorka Vuletić Mavrinac


Diabetologia Croatica | 2007

Madelung’ s disease: case report and review of the literature

Tomislav Bulum; Lea Duvnjak; Nikica Car; Željko Metelko

Collaboration


Dive into the Željko Metelko's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bojan Benko

State Intellectual Property Office

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge